Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Name: Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Author: Maraka, Stefania

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. — المؤلف: Maraka, Stefania — Cancer 20191126

المؤلف: Maraka, Stefania
النشر: Cancer 20191126
الوصف: 424-433 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Brain Neoplasms؛ Chemotherapy, Adjuvant؛ Clinical Trials, Phase II as Topic؛ Female؛ Glioblastoma